Fadi Farhat
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 35
- Cancer Treatment and Pharmacology 16
- Colorectal Cancer Treatments and Studies 9
- Pancreatic and Hepatic Oncology Research 7
- HER2/EGFR in Cancer Research 5
-
- Sarcoma Diagnosis and Treatment 6
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Joseph Kattan (40 shared papers)Marwan Ghosn (26 shared papers)Ali Shamseddine (7 shared papers)Elie Rassy (14 shared papers)Tarek Assi (11 shared papers)Fadi Nasr (12 shared papers)Fadi El Karak (14 shared papers)Georges Chahine (10 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Clinical Breast Cancer (2 papers)Chemotherapy (2 papers)Critical Reviews in Oncology/Hematology (2 papers)Supportive Care in Cancer (2 papers)
- Partner nations
- LebanonFranceUnited States
In The Last Decade
Fadi Farhat
47 papers receiving 540 citations
Peers
Comparison fields: 5 of 76
- Oncology 296
- Cancer Research 107
- Pulmonary and Respiratory Medicine 218
- Pathology and Forensic Medicine 78
- Biomaterials 34
Countries citing papers authored by Fadi Farhat
This map shows the geographic impact of Fadi Farhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Farhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Farhat more than expected).
Fields of papers citing papers by Fadi Farhat
This network shows the impact of papers produced by Fadi Farhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Farhat. The network helps show where Fadi Farhat may publish in the future.
Co-authors
The 25 scholars most cited alongside Fadi Farhat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 55 | |
| 2 | 2011 | 44 | |
| 3 | 2020 | 40 | |
| 4 | 2007 | 39 | |
| 5 | 2011 | 35 | |
| 6 | 2015 | 35 | |
| 7 | 2014 | 30 | |
| 8 | Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients. | 2006 | 30 |
| 9 | 2004 | 27 | |
| 10 | 2015 | 24 | |
| 11 | 2017 | 22 | |
| 12 | 2017 | 14 | |
| 13 | 2010 | 12 | |
| 14 | 2011 | 10 | |
| 15 | 2012 | 10 | |
| 16 | 2016 | 9 | |
| 17 | 2016 | 9 | |
| 18 | 2019 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 2016 | 8 |
About Fadi Farhat
Fadi Farhat is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 51 papers that have together received 551 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (16 papers), Cancer Genomics and Diagnostics (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Pancreatic and Hepatic Oncology Research (7 papers), Sarcoma Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Oncology (296 citations), Cancer Research (107 citations), Pulmonary and Respiratory Medicine (218 citations), Pathology and Forensic Medicine (78 citations) and Biomaterials (34 citations). Fadi Farhat has collaborated with scholars based in Lebanon, France and United States. Frequent co-authors include Joseph Kattan, Marwan Ghosn, Ali Shamseddine, Elie Rassy, Tarek Assi, Fadi Nasr, Fadi El Karak, Georges Chahine, Areej Othman and Christine Théodore. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Chemotherapy, Critical Reviews in Oncology/Hematology and Supportive Care in Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.